The Global Transcranial Magnetic Stimulator Market Growing Demand Accelerates Transcranial Magnetic Stimulator Market Growth

 


Transcranial magnetic stimulation (TMS) is a non-invasive procedure used to stimulate small targeted areas of the brain and treat neuropsychiatric conditions. It uses magnetic fields to cause electric currents in targeted regions of the brain via electromagnetic induction. TMS devices are mainly used for treatment-resistant depression and other disorders like Parkinson's disease and Alzheimer's. The global TMS market has witnessed significant growth due to increasing prevalence of neurological and psychiatric conditions globally.

 

The global transcranial magnetic stimulator market is estimated to be valued at US$ 1.42 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

The transcranial magnetic stimulator market is mainly driven by rising number of depression and neurological disorders worldwide. According to WHO, more than 264 million people of all ages suffer from depression globally. Depression is one of the leading causes of disability and results in diminished quality of life and productivity losses. Moreover, increasing geriatric population is also contributing to the growth of neurological disorders like Alzheimer's and Parkinson's disease. TMS therapy provides an effective treatment option for such patients. Another key factor fueling the market growth is approval and launch of innovative TMS devices with advanced capabilities. For instance, in May 2022, Brainsway Ltd. received FDA approval for Deep TMS H7 Coil for treatment-resistant depression. Such developments are expected to boost the adoption of TMS in the forecast period.

 

SWOT Analysis

 

Strength: Transcranial Magnetic Stimulators can treat major depression without medication in some cases. It provides an alternative non-invasive treatment option for patients who do not respond well to medication or talk therapy. The treatment is also safe when administered properly by trained medical professionals.

 

Weakness: The treatment requires patients to undergo multiple sessions, which can be an inconvenience. Some patients may also experience mild side effects such as headache or scalp discomfort during or after the procedure.

 

Opportunity: The rising mental health issues worldwide is driving the need for alternative treatment options. With further research, Transcranial Magnetic Stimulation could potentially be used to treat other conditions beyond depression such as chronic pain, Alzheimer's and cognitive impairment. This will significantly expand the clinical applications and market potential.

 

Threats: High equipment and maintenance costs could limit widespread adoption in certain regions. Strict regulatory guidelines also make the approval process longer for new clinical indications. Rising competition from alternative therapies such as Deep Brain Stimulation also poses a challenge.

 

Key Takeaways

 

The Global Transcranial Magnetic Stimulator Market Size is expected to witness high growth. It was valued at US$ 1.42 Mn in 2024 and is forecasted to reach US$ 2.32 Mn by 2031, growing at a CAGR of 5.4% during the forecast period.

 

Regional analysis: North America currently dominates the global market due to favorable reimbursement policies and regulatory approval of TMS devices for treatment-resistant depression. However, the Asia Pacific region is expected to grow at the fastest pace owing to rising geriatric population, increased awareness and healthcare expenditures.

 

Key players: Key players operating in the Transcranial Magnetic Stimulator market are Medtronic, Liva Nova PLC, Dextera Surgical Inc., Ethicon US, LLC., Synovis Micro Alliance, Inc., Vitalitec International Inc., and MAQUET Holding B. V. & Co. KG., among others. These players are focusing on new product launches, collaborations and geographic expansion strategies to strengthen their market position.


Get More Insights Here

https://www.newsstatix.com/transcranial-magnetic-stimulator-market-size-share-growth-outlook-2023/

Comments

Post a Comment

Popular posts from this blog

"Global Heparin Market: Current Trends and Future Prospects"

Image
  Heparin, a crucial anticoagulant, has been a mainstay in the pharmaceutical industry for many years. It plays a pivotal role in preventing and treating conditions such as deep vein thrombosis, pulmonary embolism, and various cardiovascular diseases. As we delve into the current state of the heparin market, we will explore the trends, challenges, and opportunities that shape this vital segment of the pharmaceutical industry. Market Overview: The global heparin market has experienced steady growth over the years, driven by an aging population, increasing cases of cardiovascular diseases, and a rising awareness of the importance of anticoagulants in healthcare. Heparin is available in various forms, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH), each with its own set of applications and market dynamics. Trends: 1.      Rising Demand for LMWH : Low molecular weight heparin is gaining popularity due to its ease of administr...
Read more

"Advancements in Cystic Fibrosis Treatment: A Comprehensive Market Analysis"

Image
  The cystic fibrosis market has seen significant advancements and changes in recent years. Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to thick and sticky mucus production that can cause serious respiratory and digestive complications. The introduction of new therapies and treatments, such as CFTR modulators, has revolutionized the management of cystic fibrosis, offering hope and improved quality of life for patients. These drugs target the underlying genetic mutations responsible for the condition, helping to alleviate symptoms and slow disease progression. However, challenges remain in the cystic fibrosis market . Access to these ground-breaking therapies can be limited due to high costs, and ongoing research is needed to develop treatments for all genetic mutations associated with the disease. Additionally, the market continues to evolve as new therapies and innovations emerge. Collaborative efforts between pharmaceutical compani...
Read more

"Advancements in Thyroid Cancer Drugs Market: A Comprehensive Analysis"

Image
  Thyroid cancer is a relatively rare but potentially life-threatening condition that affects the thyroid gland. It has been on the radar of medical researchers and pharmaceutical companies for quite some time, leading to significant advancements in the development of thyroid cancer drugs. In this blog, we will explore the latest developments in the thyroid cancer drugs market and how they are shaping the landscape of treatment options for thyroid cancer patients. 1.      Targeted Therapies: One of the most notable advancements in thyroid cancer treatment is the emergence of targeted therapies. These drugs are designed to specifically target cancer cells, sparing healthy cells and reducing side effects. Some targeted therapies approved for thyroid cancer include Sorafenib and Lenvatinib, which have shown promise in slowing down tumor growth and improving patient outcomes. 2.      Immunotherapy: Immunotherapy has gained significant at...
Read more